Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT06228417
  4. Details
NCT06228417 Clinical Trial

A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

Hypertension Clinical Trial

Official title:
Adaptive Digital Interventions Through Mobile App for Medication Adherence Improvement in Persons With Hypertension: a Pilot Study for Usability

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06228417
Other study ID # 2017_04617
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 23, 2020
Est. completion date March 1, 2021

Study information
Verified date March 2024
Source Halmstad University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A development and pilot test of an app targeting persons with hypertension. Content in the app was based on persons with hypertensions experiences and a literature review. The participants experience of using the app as well as testing a instrument for medication adherence.

Recruitment information / eligibility
Status Completed
Enrollment 14
Est. completion date March 1, 2021
Est. primary completion date February 27, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria: - 40-70 years of age, - have hypertension (i.e., ICD 10 codes I10-I15 in the person's medical history) for =1 year - have been prescribed medications to treat said hypertension - speak and understand Swedish - have a smartphone Exclusion Criteria: - having received medication with unit-dose packages (Apodos) - previous stroke - previous myocardial infarction - psychological disorder or cognitive impairment (i.e. ICD 10 codes F01-F99) - pregnancy-induced hypertension´ - insulin treatment - kidney disease, defined as glomerulus filtration rate (GFR) <60 ml/min.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Adaptive digital intervention
Participants received reminder for medication intake on daily basis. Also, short message regarding hypertension, medication and lifestyle changes

Locations
Country Name City State
Sweden Halmstad University Halmstad

Sponsors (2)
Lead Sponsor Collaborator
Halmstad University Vinnova

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Medication adherence Medication adherence measured by the participants self-reported intake of daily medication in the app.
The usage is described in frequencies and response time.		 two weeks
Primary Adherence hypertension medication Medication score through the Maastricht Utrecht Adherence in Hypertension (MUAH-16) questionnaire.
The questionnaire consists of four subscales: two of them measures positive and two others measures negative aspects of attitudes to medication adherence and health problem. Min value for each subscale are 4 and maximum 28. Higher value indicate better outcome		 two weeks
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A